Similar Items: Soluble ST2 as a biomarker for predicting severe adverse events among pediatric patients with Mycoplasma pneumoniae pneumonia
- Association analysis of Mycoplasma pneumoniae 23S rRNA gene mutation with refractory Mycoplasma pneumoniae pneumonia in children
- Mycoplasma pneumoniae Infections in Hospitalized Children - United States, 2018-2024
- Serum levels of PTEN and progranulin as potential diagnostic and prognostic biomarkers for severe pneumonia in the elderly
- Value of procalcitonin as a biomarker for postoperative hospital-acquired pneumonia after ...
- Incidence and risk factors of perioperative respiratory adverse events in pediatric surgical patients: Development and validation of a predictive model in Brazil
- Study on the mortality risk and predictive model for COVID-19 inpatients with pneumonia manifestations